FluroTech Ltd.

FluroTech Ltd.

FLURF
FluroTech Ltd.US flagOther OTC
0.00
USD
- -
- -
447,175.00Market Cap
FluroTech Ltd.
FLURF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.26
-0.11
-0.2
-0.11
-0.12
-0.09
-0.1
-2.39
-1.44
-0.74
-1.56
-0.14
-0.01
-0.06
Basic EPS, GAAP
-0.17
-0.07
-0.27
-0.09
-0.11
-0.08
-0.1
-2.25
-1.23
-0.55
-0.41
-0.02
-0.02
-0.06
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.32
-0.39
-0.63
-0.81
-0.93
-1.02
-1.11
1.42
0.11
-0.6
-0.54
-0.6
-0.61
-0.29
Book Value per Share
0.99
0.76
0.64
0.6
0.47
0.39
0.29
2.65
1.01
0.13
0.11
-0.01
-0.02
-0.01
Tangible Book Value per Share
- -
1
- -
- -
- -
- -
- -
2
3
4
7
8
8
17
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
-5
-4
-3
-11
-1
- -
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
5
3
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
6
3
- -
1
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.11
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-257.5
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
23
23
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
- -
- -
Payables & Accruals
1
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
416.67%
-13.66%
107.6%
Free Cash Flow
1,038.17%
-29.49%
-23.99%
Net Income, GAAP
1,153.42%
12.68%
-91.19%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.04
-0.02
-0.01
- -
-0.14
2023
- -
- -
- -
- -
-0.01
2024
-0.03
-0.02
-0.02
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
FluroTech Ltd. (TSXV:TEST.H; OTC:FLURF) operates as a technology and marketing company focused on the commercialization of spectroscopy-based technologies for testing and identifying organic and inorganic compounds in biological samples, primarily derived from cannabis and hemp plants; its core offerings include the proprietary CompleTest instrument and associated consumable testing kits developed in collaboration with the University of Calgary and University of Alberta. The company targets the cannabis industry with fluorescence spectroscopy solutions for analytical testing, serving laboratory and scientific applications in biotechnology research. Founded in 2018 and headquartered in Calgary, Alberta, Canada, FluroTech conducts operations principally in Canada with no significant international geographic footprint beyond North American listings. In recent developments, FluroTech pursued a major strategic shift through a proposed reverse takeover and change of business via the acquisition of Great Slave Helicopters 2018 Ltd. (GS Heli), a Yellowknife-based provider of specialized helicopter aviation services and logistical support across northern Canada including the Northwest Territories, Yukon, Nunavut, Saskatchewan, Alberta, Northwest Ontario, and British Columbia; the transaction, announced with a definitive agreement in April 2024 and backed by a $22 million equity financing and $35 million senior debt facility, aimed to rebrand the company as Consolidated Aerospace Finance Corporation and pivot to an aerospace consolidation strategy, but terminated in October 2024 due to unfavorable market conditions. Subsequently, FluroTech completed a $1 million non-brokered private placement in April 2024, executed a 15:1 share consolidation, settled outstanding debts, transferred its listing to the TSXV NEX board in October 2023 for non-compliance with Tier 2 requirements, and underwent significant board changes including multiple resignations and appointments through June 2025 such as the addition of Eric Corbett while addressing ongoing compliance efforts.

Company News

APIChatGPT
  • FluroTech Ltd. Announces Application for Resumption of Trading, AGM Deficiency Update, and CFO Appointment

  • FluroTech Ltd. Announces Change in Directors

  • FluroTech Ltd. Announces Change in Management and Directors

  • FluroTech Ltd. Announces Change in Management and Directors

  • FluroTech Ltd. Announces Termination of Definitive Agreement with Great Slave Helicopters 2018 Ltd.

  • FluroTech, to be renamed Consolidated Aerospace Finance Corporation, Announces $22 Million Equity Financing

  • FluroTech Announces Debt Settlement Agreement

  • FluroTech Announces Closing of Oversubscribed Private Placement Financing

  • FluroTech and GS Heli Announce Execution of Definitive Agreement

  • FluroTech Enters into a Non-Binding Letter of Intent for Change of Business Transaction

  • FluroTech Enters into Non-Binding Letter of Intent for Reverse Take-Over Transaction and Officer and Board Appointment

  • Danny Dalla-Longa Announces Filing of Early Warning Report Related to FluroTech Ltd

  • FluroTech Ltd. Announces Transfer to NEX Exchange

  • FluroTech Ltd. Announces Termination of Letter of Intent with Renewable Geo Resources Ltd.

  • Former US Assistant Health Secretary Dr. Joxel Garcia Joins FluroTest as Chief Medical Officer and Executive Team Member

  • FluroTech Announces Warrant Incentive Program Results Adding Over $1M to Company Treasury

  • FluroTest Provides Clinical Trial Update for High Volume COVID-19 Rapid Antigen Testing System

  • FluroTest Prepares to Detect SARS-CoV-2 Variants of Concern with High-Throughput COVID-19 Testing Platform

  • FluroTest Diagnostics Systems and Total Testing Solutions Sign Pilot Program MOU to Bring First High-Volume SARS-CoV-2 Testing System to California

  • FluroTech Announces Early Warrant Exercise Incentive Program